The coagulopathy of COVID-19 is characterised by significantly elevated D Dimer and
fibrinogen, mild thrombocytopenia and a mildly prolonged PT/APTT. A high incidence of …

Background Neurological manifestations of severe acute respiratory syndrome coronavirus
2 (SARS‐CoV‐2) are being widely documented. However, movement disorders in the …

The pandemic of coronavirus disease 2019 (COVID‐19) is continually worsening. Clinical
treatment for COVID‐19 remains primarily supportive with no specific medicines or …

The immune response to COVID-19 infection is variable. How COVID-19 influences clinical
outcomes in hospitalized patients needs to be understood through readily obtainable …

The immunosuppression and inhibition of hematopoiesis are considered to be reasons for
the development of complications after intensive chemotherapy and allogeneic …

Mesenchymal stem cells (MSC) are characterized by tolerogenic potential and therefore, are
used in the treatment of autoimmune diseases such as graft-versus-host disease (GVHD) …

COVID-19 pneumonia caused by severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2) has ravaged the world, resulting in an alarming number of infections and deaths …

Актуальность. Новая коронавирусная инфекция, вызванная вирусом SARS-CoV-2,
характеризуется системной гипервоспалительной реакцией с выраженным …

The well documented association between obesity and the severity of SARS-CoV-2 infection
raises the question of whether adipose tissue (AT) is impacted during this infection. Using a …

Rationale: Trauma, surgery, and infection can cause severe inflammation. Both
dysregulated inflammation intensity and duration can lead to significant tissue injuries …